Skip to content

Arcus Biosciences, Inc.

RCUS

CIK 0001724521

← back to feed
Revenue (TTM)
$29M
−35.3% YoY Q1 Apr 2026
Net Income (TTM)
−$375M
−24.7% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$3.43
−4.8% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-1,400.0%
Q1 Apr 2026
Net Margin
-1,293.1%
Q1 Apr 2026
Free Cash Flow (TTM)
−$378M
Q1 Apr 2026
Cash
$201M
Q1 Apr 2026
Total Debt
$100M
Q1 Apr 2026
Shares Outstanding
125.77M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings